Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Past present and future of radiosensitization in cervical cancer.
Journal: Frontiers in oncology
Published: April 03, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses.
Journal: Cancer letters
Published: January 09, 2026
FZD7 expression marks mammary tumor-initiating cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 11, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 11, 2025
Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment.
Journal: Molecules (Basel, Switzerland)
Published: November 01, 2024
Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapies.
Journal: NPJ precision oncology
Published: October 01, 2024
A FZD7-specific Antibody-Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models.
Journal: Molecular cancer therapeutics
Published: June 20, 2021
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy.
Journal: Nature communications
Published: June 14, 2021
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 08, 2021
Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs.
Journal: Pharmaceutics
Published: January 31, 2021
Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors.
Journal: Biomaterials
Published: December 06, 2019
Last Updated: 09/26/2026